Note 2 - Acquisitions - Preliminary and Final Fair Value of Assets and Liabilities Assumed (Details) - USD ($) $ in Thousands |
|
|
|
|
5 Months Ended |
6 Months Ended |
10 Months Ended |
12 Months Ended |
Jun. 30, 2018 |
Feb. 01, 2018 |
Jan. 02, 2018 |
Sep. 05, 2017 |
Jun. 30, 2018 |
Jun. 30, 2018 |
Jun. 30, 2018 |
Jun. 30, 2018 |
Jun. 30, 2017 |
Jun. 30, 2016 |
Goodwill |
$ 597,890
|
|
|
|
$ 597,890
|
$ 597,890
|
$ 597,890
|
$ 597,890
|
$ 579,026
|
$ 430,882
|
Goodwill, Purchase Accounting Adjustments |
|
|
|
|
|
|
|
|
1,809
|
|
Payments to Acquire Businesses, Net of Cash Acquired, Total |
|
|
|
|
|
|
|
67,851
|
253,785
|
91,423
|
Cash paid, net of cash acquired |
|
|
|
|
|
|
|
67,851
|
$ 253,785
|
$ 91,423
|
Trevigen Inc. [Member] |
|
|
|
|
|
|
|
|
|
|
Current assets, net of cash |
1,662
|
|
|
$ 1,662
|
1,662
|
1,662
|
1,662
|
1,662
|
|
|
Adjustments to fair value, current assets, net of cash |
|
|
|
|
|
|
|
|
|
|
Equipment and other long-term assets |
53
|
|
|
154
|
53
|
53
|
53
|
53
|
|
|
Adjustments to fair value, equipment and other long-term assets |
|
|
|
|
|
|
(101)
|
|
|
|
Goodwill |
5,991
|
|
|
4,595
|
5,991
|
5,991
|
5,991
|
5,991
|
|
|
Goodwill, Purchase Accounting Adjustments |
|
|
|
|
|
|
1,396
|
|
|
|
Total assets acquired |
13,226
|
|
|
13,511
|
13,226
|
13,226
|
13,226
|
13,226
|
|
|
Adjustments to fair value, total assets acquired |
|
|
|
|
|
|
(285)
|
|
|
|
Liabilities |
387
|
|
|
92
|
387
|
387
|
387
|
387
|
|
|
Adjustments to fair value, liabilities |
|
|
|
|
|
|
295
|
|
|
|
Deferred income taxes, net |
2,195
|
|
|
2,785
|
2,195
|
2,195
|
2,195
|
2,195
|
|
|
Adjustments to fair value, deferred income taxes, net |
|
|
|
|
|
|
(590)
|
|
|
|
Net assets acquired |
10,644
|
|
|
10,634
|
10,644
|
10,644
|
10,644
|
10,644
|
|
|
Adjustments to fair value, net assets acquired |
|
|
|
|
|
|
10
|
|
|
|
Payments to Acquire Businesses, Net of Cash Acquired, Total |
10,644
|
|
|
10,634
|
|
|
|
|
|
|
Adjustments to fair value, cash paid, net of cash acquired |
|
|
|
|
|
|
10
|
|
|
|
Cash paid, net of cash acquired |
10,644
|
|
|
10,634
|
|
|
|
|
|
|
Trevigen Inc. [Member] | Developed Technology Rights [Member] |
|
|
|
|
|
|
|
|
|
|
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles |
5,100
|
|
|
3,800
|
5,100
|
5,100
|
5,100
|
5,100
|
|
|
Adjustments to fair value, intangible assets |
|
|
|
|
|
|
1,300
|
|
|
|
Trevigen Inc. [Member] | Customer Relationships [Member] |
|
|
|
|
|
|
|
|
|
|
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles |
260
|
|
|
1,900
|
260
|
260
|
260
|
260
|
|
|
Adjustments to fair value, intangible assets |
|
|
|
|
|
|
(1,640)
|
|
|
|
Trevigen Inc. [Member] | Trade Names [Member] |
|
|
|
|
|
|
|
|
|
|
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles |
160
|
|
|
$ 1,400
|
160
|
160
|
160
|
160
|
|
|
Adjustments to fair value, intangible assets |
|
|
|
|
|
|
(1,240)
|
|
|
|
Atlanta Biologicals [Member] |
|
|
|
|
|
|
|
|
|
|
Current assets, net of cash |
15,722
|
|
$ 18,678
|
|
15,722
|
15,722
|
15,722
|
15,722
|
|
|
Adjustments to fair value, current assets, net of cash |
|
|
|
|
|
(2,956)
|
|
|
|
|
Equipment and other long-term assets |
4,901
|
|
4,348
|
|
4,901
|
4,901
|
4,901
|
4,901
|
|
|
Adjustments to fair value, equipment and other long-term assets |
|
|
|
|
|
553
|
|
|
|
|
Goodwill |
10,195
|
|
21,695
|
|
10,195
|
10,195
|
10,195
|
10,195
|
|
|
Goodwill, Purchase Accounting Adjustments |
|
|
|
|
|
(11,500)
|
|
|
|
|
Total assets acquired |
59,718
|
|
56,221
|
|
59,718
|
59,718
|
59,718
|
59,718
|
|
|
Adjustments to fair value, total assets acquired |
|
|
|
|
|
3,497
|
|
|
|
|
Liabilities |
90
|
|
90
|
|
90
|
90
|
90
|
90
|
|
|
Adjustments to fair value, liabilities |
|
|
|
|
|
|
|
|
|
|
Deferred income taxes, net |
8,354
|
|
4,845
|
|
8,354
|
8,354
|
8,354
|
8,354
|
|
|
Adjustments to fair value, deferred income taxes, net |
|
|
|
|
|
3,509
|
|
|
|
|
Net assets acquired |
51,274
|
|
51,286
|
|
51,274
|
51,274
|
51,274
|
51,274
|
|
|
Adjustments to fair value, net assets acquired |
|
|
|
|
|
(12)
|
|
|
|
|
Payments to Acquire Businesses, Net of Cash Acquired, Total |
51,274
|
|
51,286
|
|
|
|
|
|
|
|
Adjustments to fair value, cash paid, net of cash acquired |
|
|
|
|
|
(12)
|
|
|
|
|
Cash paid, net of cash acquired |
51,274
|
|
51,286
|
|
|
|
|
|
|
|
Atlanta Biologicals [Member] | Developed Technology Rights [Member] |
|
|
|
|
|
|
|
|
|
|
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles |
23,000
|
|
9,000
|
|
23,000
|
23,000
|
23,000
|
23,000
|
|
|
Adjustments to fair value, intangible assets |
|
|
|
|
|
14,700
|
|
|
|
|
Atlanta Biologicals [Member] | Customer Relationships [Member] |
|
|
|
|
|
|
|
|
|
|
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles |
3,600
|
|
1,500
|
|
3,600
|
3,600
|
3,600
|
3,600
|
|
|
Adjustments to fair value, intangible assets |
|
|
|
|
|
1,400
|
|
|
|
|
Atlanta Biologicals [Member] | Trade Names [Member] |
|
|
|
|
|
|
|
|
|
|
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles |
2,300
|
|
$ 1,000
|
|
2,300
|
2,300
|
2,300
|
2,300
|
|
|
Adjustments to fair value, intangible assets |
|
|
|
|
|
1,300
|
|
|
|
|
Eurocell Diagnostics, SAS [Member] |
|
|
|
|
|
|
|
|
|
|
Current assets, net of cash |
512
|
$ 512
|
|
|
512
|
512
|
512
|
512
|
|
|
Adjustments to fair value, current assets, net of cash |
|
|
|
|
|
|
|
|
|
|
Equipment and other long-term assets |
188
|
188
|
|
|
188
|
188
|
188
|
188
|
|
|
Adjustments to fair value, equipment and other long-term assets |
|
|
|
|
|
|
|
|
|
|
Goodwill |
2,910
|
113
|
|
|
2,910
|
2,910
|
2,910
|
2,910
|
|
|
Goodwill, Purchase Accounting Adjustments |
|
|
|
|
2,797
|
|
|
|
|
|
Total assets acquired |
9,882
|
7,085
|
|
|
9,882
|
9,882
|
9,882
|
9,882
|
|
|
Adjustments to fair value, total assets acquired |
|
|
|
|
2,797
|
|
|
|
|
|
Liabilities |
483
|
483
|
|
|
483
|
483
|
483
|
483
|
|
|
Adjustments to fair value, liabilities |
|
|
|
|
|
|
|
|
|
|
Deferred income taxes, net |
2,070
|
2,070
|
|
|
2,070
|
2,070
|
2,070
|
2,070
|
|
|
Adjustments to fair value, deferred income taxes, net |
|
|
|
|
|
|
|
|
|
|
Net assets acquired |
7,329
|
4,532
|
|
|
7,329
|
7,329
|
7,329
|
7,329
|
|
|
Adjustments to fair value, net assets acquired |
|
|
|
|
2,797
|
|
|
|
|
|
Payments to Acquire Businesses, Net of Cash Acquired, Total |
5,933
|
3,136
|
|
|
|
|
|
|
|
|
Adjustments to fair value, cash paid, net of cash acquired |
|
|
|
|
2,797
|
|
|
|
|
|
Cash paid, net of cash acquired |
5,933
|
3,136
|
|
|
|
|
|
|
|
|
Business Combination, Consideration Transferred, Liabilities Incurred |
1,396
|
1,396
|
|
|
|
|
|
|
|
|
Adjustments to fair value, Consideration payable |
|
|
|
|
|
|
|
|
|
|
Eurocell Diagnostics, SAS [Member] | Customer Relationships [Member] |
|
|
|
|
|
|
|
|
|
|
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles |
$ 6,272
|
$ 6,272
|
|
|
6,272
|
$ 6,272
|
$ 6,272
|
$ 6,272
|
|
|
Adjustments to fair value, intangible assets |
|
|
|
|
|
|
|
|
|
|